Sign in

CIK 0001844417

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Estrella Immunopharma, Inc.

Sign in to watch
Ticker
ESLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
861314502
Phone
+1 510-318-9098
Business address
5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
Former names
TradeUP Acquisition Corp.

Securities

  • ESLA Common Stock Nasdaq
  • ESLAW Warrant Nasdaq
  1. 425 Deal Prospectus/Communication re Business Combination
  2. 8-K Event Shareholder vote results · Other events
  3. 425 Deal Prospectus/Communication re Business Combination
  4. 8-K Event Material agreement · Unregistered share sale
  5. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  6. 425 Deal Prospectus/Communication re Business Combination
  7. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
  8. 8-K Event Material agreement · Bylaws or fiscal year change · Shareholder vote results · Other events
  9. 8-K Event Other events
  10. S-4/A Deal Registration Statement - Business Combination
  11. S-4/A Deal Registration Statement - Business Combination
  12. S-4/A Deal Registration Statement - Business Combination
  13. 8-K Event Delisting notice
  14. 425 Deal Prospectus/Communication re Business Combination
  15. 8-K Event Material agreement
  16. S-4/A Deal Registration Statement - Business Combination
  17. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  18. 425 Deal Prospectus/Communication re Business Combination
  19. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
  20. S-4/A Deal Registration Statement - Business Combination

Page 3 of 5 · 87 filings